Terazosin Hydrochloride Dihydrate ≥98%|CAS:70024-40-7|50 mg|250 mg|1 g

Heitrin; Hytracin; Hytrin; Hytrinex; Itrin; Urodie; Vasocard|Terazosin is a quinazoline compound that inhibits 1-adrenergic receptors, exhibiting antihypertensive, anti-metastatic, and anticancer activities. Terazosin is clinically used to treat benign prostatic hyperplasia (BPH) and hypertension. In prostate cells, terazosin increases activation of caspase 3 and induces apoptosis. In prostate cancer cells, this compound induces apoptosis and inhibits cellular proliferation, invasion, and migration.|C19H25N5O4 HCl 2H2O|459.93|A White to off White Powder|Ambient|Soluble in water.